Virginia BME

The University of Delaware's Biomedical Engineering Department is looking for a passionate and dedicated Academic Advisor II to join their team! 🎓 🌟UD Careers (link below) #udbme careers.udel.edu/cw/en-us/job/5…

Upcoming CVRC/CVTG Career Development -Negotiation, Difficult Conversations, and Self-Advocacy featuring Dr. Nikki Hastings on March 10, 2025

Thanks to everyone who came out to celebrate @UVA Innovators of the Year Silvia Blemker, Craig Meyer and Joe Hart! #GreatAndGood #TechTransfer #UVALVG @UVAEngineers

Everyone knows the health risks of carrying too much fat around the waist and hips, but @MedicineUVA scientists have developed a noninvasive way to assess the health risks of unseen fat around the heart. 🫀 Learn more: bit.ly/4aCdLxN

Jeff Saucerman, PhD, and his research group combine computational and experimental methods to identify new drugs for heart disease. They find new uses for existing drugs already approved for other conditions. #BiomedicalEngineering #CardiovascularMedicine

Pleased to welcome Joel Collier @DukeU as this Friday's seminar guest!

At UVA, students from opposing sides find all kinds of ways to come together!

A progress report from our 1st Milton Adams Fellowship award! Graham Lenert and Noah Perry in @mete_civelek lab are investigating how heart attacks are experienced differently in men and women. The Adams Fellowship is helping them disseminate their work: engineering.virginia.edu/department/bio…

Congrats to BME professor Silvia Blemker on her election as Fellow of the National Academy of Inventors! Read about the fascinating work Silvia does and her successful efforts to translate research into products that help people. at.virginia.edu/z3fu3l @UVABME @AcadofInventors

Jeff Saucerman advisee Malcolm O’Malley helped NASA researchers make sense of life sciences data to mitigate impacts of space travel on our immune systems. at.virginia.edu/2lggs9 @UVABME @spacedailycom @jsauce7 @NASA

Matthew Lazzara and his team of researchers have found multiple ways to interrupt a process in pancreatic cancer cells that makes them more resistant to chemotherapy, potentially leading to better treatments for patients. at.virginia.edu/6j2tla @uvachechair @cr_aacr

New insights from research led by UVA Engineering professor Kevin Janes could change the game for treating viral heart infections and preventing heart failure. at.virginia.edu/pf96hx @UVABME @ScienceAdvances

Assistant professor Sepideh Dolatshahi and Ph.D. student Remziye Wessel lead research on vaccines that may help save more moms and newborns with personalized therapies. at.virginia.edu/7r9v9b @UVABME

UVA biomedical engineering researchers have developed an MRI technique to analyze the fat surrounding a patient’s heart, potentially enabling earlier heart disease interventions. Read more: at.virginia.edu/bu6ofs @UVABME @EarthDotCom

New research from BME Ph.D. student Jordan Reed and her UVA team showed how weight and metabolism are likely determined more by a person’s genetics than their diet. Read more: at.virginia.edu/mavqf3 @iScience_CP @UVABME

Prof. Kevin Janes discusses his research on cancer and infectious disease for Research in Motion: “We combine quantitative experiments in the laboratory with computer models that formalize how we think the disease works.” @UVABME @MedicineUVA Watch here: at.virginia.edu/4wsheo

We cleared out all the people and backpacks this morning, to show off the @UVA booth at the @BMESociety national meeting. Designed by @ahnasee at Mountain High Media with help from @iamdjamison. Looking good! Now time to break it all down!

Here's a group photo from the Coulter Fellowship Program! Currently in its third year of funding, the program has provided $117,500 in stipend support to 50 BME students during summer industry internships. @UVABME

Congrats to BME professor Shayn Peirce-Cottler for receiving the 2024 Eugene M. Landis award from The Microcirculatory Society! The award recognizes Peirce-Cottler for her lab's research on microvasculature and its role in diseases. @The_MCSociety @uvabme at.virginia.edu/rk9cpz

Tempo Therapeutics, founded by BME & CHE associate professor Donald Griffin, recently dosed the first patients in their TT101 trial. TT101 is a solution designed to regrow large volumes of tissue while preventing disfiguring scars for skin cancer patients. @uvachechair @uvabme